Moreover, the frequency of detected mutations does not depend on the patients’ age, lymph node metastasis, ER, PR or HER2 status and Bloom Richardson Scale (Table 2, Table S1). The gene discussed is ERBB2; the disease is metastatic malignant neoplasm in the lymph nodes.